Fabtech swings to ₹4.2 Cr consolidated Q1 profit YoY; revenue up just 10%, dips QoQ on seasonality

Fabtech Technologies posted a clean year-on-year turnaround in Q1 FY27: consolidated PAT of ₹4.21 Cr against a ₹6.13 Cr loss a year ago, on revenue of ₹74.98 Cr (+10.3% YoY). Net margin swung to ~5.6% from -8.9%, and — importantly — the improvement is understated by the headline, because the year-ago loss was actually cushioned by a ₹1.77 Cr exceptional gain (sale of a 51% LLP stake). Strip that out and the underlying swing, from roughly a ₹7.9 Cr operating loss to a ₹4.2 Cr profit, is larger than the reported one. This quarter carries no exceptional item.

The sequential picture looks weak on the surface — revenue -52.7% and PAT -80.9% versus Q4 FY26 — but that is a seasonality artifact, not deterioration: Fabtech is a turnkey pharma-engineering project business whose revenue is heavily back-half/Q4-weighted (Q1 FY26 was ₹68 Cr against a ₹159 Cr Q4). The QoQ drop should be read as the normal start-of-year trough, which is why YoY is the right lens here. The consolidated result also leans on the overseas arm: standalone PAT was only ₹1.06 Cr (itself a turnaround from a ₹9.16 Cr loss), while UAE subsidiary Fabtech Technologies LLC contributed ~₹3.81 Cr — a >3x divergence readers will notice, so the consolidated figure is the fair basis.

The stock went into the print at ₹149.73, down 5.1% over the past month of trading.

Against management's own FY27 guidance — ~25% revenue growth and a 9.5-10.5% PAT margin, backed by a >₹900 Cr order book and GCC/Africa expansion — Q1 is running behind on both counts (+10% growth, 5.6% NPM), consistent with a back-half-loaded year but a gap that H2 execution must close. No brokerage publishes quarterly consensus for this recently-listed micro-cap, so there is no street bar to beat. Concurrent board actions align with the confident tone struck on the Q4 concall: a ₹0.60/share FY26 final dividend, chairperson re-appointment, and an approved ODI of up to ₹24 Cr into the UAE subsidiary plus a new Saudi step-down entity — capital being pushed toward the same overseas geographies now carrying the P&L. The item to watch is receivables at ₹214.9 Cr against ₹75 Cr of quarterly revenue.